Infliximab in active early rheumatoid arthritis | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Extended report

Infliximab in active early rheumatoid arthritis

Authors

F C Breedveld PubMed articles Google scholar articles
P Emery PubMed articles Google scholar articles
E Keystone PubMed articles Google scholar articles
K Patel PubMed articles Google scholar articles
D E Furst PubMed articles Google scholar articles
J R Kalden PubMed articles Google scholar articles
E W St Clair PubMed articles Google scholar articles
M Weisman PubMed articles Google scholar articles
J Smolen PubMed articles Google scholar articles
P E Lipsky PubMed articles Google scholar articles
R N Maini PubMed articles Google scholar articles

Correspondence to:
Professor F C Breedveld
Department of Rheumatology, University of Leiden, Albinusdreef 2, Postbus 9600, 2300 RC Leiden, The Netherlands; f.c.breedveldlumc.nl

Citation

Breedveld FC, Emery P, Keystone E, et al

Infliximab in active early rheumatoid arthritis

Annals of the Rheumatic Diseases 2004;63:149-155.

Publication history

Accepted November 3, 2003
First published January 13, 2004.

Online issue publication

October 25, 2017

Copyright information

Copyright 2004 by Annals of the Rheumatic Diseases